Suchergebnisse - "Liu, Shengwu"

PubPharm (6)

1

Mobocertinib in non-small cell lung cancer

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2022

von Liu, S. | Lowder, K.

2

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Li, S. | Liu, S. | Deng, J. | +24

3

Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Liu, S. | Li, S. | Hai, J. | +8

CommentIn: Clin Cancer Res. 2018 Jun 1;24(11):2470-2472. - PMID 29496760

4

Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer

enthalten in: Nature medicine | 2018

von Robichaux, J. | Elamin, Y. | Tan, Z. | +21

CommentIn: Nat Rev Clin Oncol. 2018 Jul;15(7):404. - PMID 29743681

5

Synergy of WEE1 and mTOR Inhibition in Mutant KRAS-Driven Lung Cancers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Hai, J. | Liu, S. | Bufe, L. | +8

6

Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation

enthalten in: PloS one | 2017

von Wang, H. | Liu, S. | Liu, S. | +7

1
[1]